One of biotech's biggest collaboration deals on record surfaced on 7 January when Genzyme told analysts and investors that it had signed a potential $1.9 billion agreement with Isis ...

A look at the current state of Syria amidst war and chaos in 2017, featuring stories of survival and observations by political experts from around the world.